• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威东南部前瞻性基于人群发病队列(IBSEN 研究)中溃疡性结肠炎患者诊断 20 年后的结局。

Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.

机构信息

Department of Gastroenterolgy, Oslo University Hospital, Ulleval, Norway.

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

J Crohns Colitis. 2021 Jun 22;15(6):969-979. doi: 10.1093/ecco-jcc/jjaa232.

DOI:10.1093/ecco-jcc/jjaa232
PMID:33367569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8218709/
Abstract

BACKGROUND AND AIMS

The long-term course of ulcerative colitis [UC] is difficult to predict. Mortality, colectomy, cancer, and hospitalisation represent hard outcomes of disease. Moreover, knowledge on the risk of relapses and need for potent medication add important information about living with UC. We aimed to evaluate the course and prognosis of UC during the first 20 years after diagnosis, and to identify early prognostic risk factors.

METHODS

From 1990 to 1994, a population-based inception cohort of patients with inflammatory bowel disease was enrolled in South-Eastern Norway. A systematic follow-up [FU] was conducted at 1,5, 10, and 20 years after diagnosis. Clinical outcomes were recorded continuously, and possible relationships between early disease characteristics and outcomes were analysed using multiple regression analysis.

RESULTS

Among 519 UC patients, 119 died, 60 were lost to FU, and 340 were included in the FU cohort. The 20-year cumulative risk of colectomy was 13.0% (95% confidence interval [CI] [11.4-14.6]). Extensive colitis at diagnosis was independently associated with an increased risk of colectomy compared with proctitis (hazard ratio [HR] = 2].8, 95% CI [1.3-6.1]). In contrast, mucosal healing at 1-year FU was independently associated with reduced risk of colectomy [HR = 0.4, 95% CI [0.2-0.8]), and inversely associated with subsequent risk of relapse [adjusted HR = 0.5, 95% CI [0.3-0.7]).

CONCLUSIONS

The overall risk of colectomy in our cohort was lower than expected from previous studies, although considerable for patients with extensive colitis at diagnosis. Early mucosal healing was associated with better disease outcomes 20 years after diagnosis.

摘要

背景和目的

溃疡性结肠炎(UC)的长期病程难以预测。死亡率、结肠切除术、癌症和住院治疗是疾病的严重后果。此外,了解复发风险和需要强效药物的情况,对于了解 UC 的患者生活状况具有重要意义。本研究旨在评估诊断后 20 年内 UC 的病程和预后,并确定早期预后危险因素。

方法

1990 年至 1994 年,在挪威东南部进行了一项基于人群的炎症性肠病发病队列研究。在诊断后 1、5、10 和 20 年进行系统随访。连续记录临床结局,并使用多元回归分析分析早期疾病特征与结局之间的可能关系。

结果

在 519 例 UC 患者中,119 例死亡,60 例失访,340 例纳入随访队列。20 年累积结肠切除术风险为 13.0%(95%置信区间 [CI] [11.4-14.6])。诊断时为广泛性结肠炎与诊断时为直肠炎相比,结肠切除术风险增加(风险比 [HR] 2.8,95%CI [1.3-6.1])。相反,1 年 FU 时黏膜愈合与结肠切除术风险降低独立相关(HR 0.4,95%CI [0.2-0.8]),与随后的复发风险降低相关(调整 HR 0.5,95%CI [0.3-0.7])。

结论

本队列的总体结肠切除术风险低于以往研究,但对于诊断时为广泛性结肠炎的患者仍然较高。早期黏膜愈合与诊断后 20 年的疾病结局更好相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/8daf419d35b8/jjaa232f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/52d64bf8d115/jjaa232f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/ca0e5f3a6b87/jjaa232f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/b2a2a6b01680/jjaa232f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/5aa1621d6dab/jjaa232f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/0bffff66bd1e/jjaa232f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/278a6f34c200/jjaa232f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/8daf419d35b8/jjaa232f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/52d64bf8d115/jjaa232f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/ca0e5f3a6b87/jjaa232f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/b2a2a6b01680/jjaa232f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/5aa1621d6dab/jjaa232f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/0bffff66bd1e/jjaa232f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/278a6f34c200/jjaa232f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/8218709/8daf419d35b8/jjaa232f0007.jpg

相似文献

1
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.挪威东南部前瞻性基于人群发病队列(IBSEN 研究)中溃疡性结肠炎患者诊断 20 年后的结局。
J Crohns Colitis. 2021 Jun 22;15(6):969-979. doi: 10.1093/ecco-jcc/jjaa232.
2
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).溃疡性结肠炎最初10年的临床病程:基于人群的发病队列研究结果(IBSEN研究)
Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.
3
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.溃疡性结肠炎的临床病程:诊断后第一年频繁使用生物制剂和低结肠切除术率——来自 IBSEN III 起始队列的结果。
Aliment Pharmacol Ther. 2024 Aug;60(3):357-368. doi: 10.1111/apt.18097. Epub 2024 Jun 4.
4
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.在一个未经挑选的欧洲队列中,溃疡性结肠炎患者接受低位结肠切除术的比例随访了10年。
Gastroenterology. 2007 Feb;132(2):507-15. doi: 10.1053/j.gastro.2006.11.015. Epub 2006 Nov 15.
5
Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.韩国首尔松坡-江东地区基于人群队列的溃疡性结肠炎长期预后及其在1986年至2015年间的时间变化
Gut. 2020 Aug;69(8):1432-1440. doi: 10.1136/gutjnl-2019-319699. Epub 2019 Dec 10.
6
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.欧洲基于人群的发病队列中溃疡性结肠炎患者在随访的头 5 年中的自然病程:Epi-IBD 研究。
J Crohns Colitis. 2019 Feb 1;13(2):198-208. doi: 10.1093/ecco-jcc/jjy154.
7
Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).在一项基于人群的溃疡性结肠炎患者研究(IBSEN研究)中用于预测结肠切除术的风险矩阵模型。
Scand J Gastroenterol. 2015;50(12):1456-62. doi: 10.3109/00365521.2015.1064991. Epub 2015 Jul 3.
8
Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.基于人群队列的成人溃疡性结肠炎自然史:系统评价。
Clin Gastroenterol Hepatol. 2018 Mar;16(3):343-356.e3. doi: 10.1016/j.cgh.2017.06.016. Epub 2017 Jun 16.
9
Does Hospitalization Predict the Disease Course in Ulcerative Colitis? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Ulcerative Colitis in a Population-based Inception Cohort (2000-2012).住院治疗能否预测溃疡性结肠炎的疾病进程?基于人群的初始队列研究(2000 - 2012年)中溃疡性结肠炎住院及再次住院的患病率和预测因素。
J Gastrointestin Liver Dis. 2015 Sep;24(3):287-92. doi: 10.15403/jgld.2014.1121.243.pag.
10
Presenting features and disease course of pediatric ulcerative colitis.呈现小儿溃疡性结肠炎的特征和疾病进程。
J Crohns Colitis. 2013 Dec;7(11):e509-15. doi: 10.1016/j.crohns.2013.03.007. Epub 2013 Apr 11.

引用本文的文献

1
Social alienation in patients with inflammatory bowel diseases: A latent profile analysis.炎症性肠病患者的社会疏离感:一项潜在剖面分析。
Int J Nurs Sci. 2025 Jun 18;12(4):335-343. doi: 10.1016/j.ijnss.2025.06.007. eCollection 2025 Jul.
2
Objective Treatment Targets and Their Correlation with Patient-Reported Outcomes in Inflammatory Bowel Disease: A Real-World Study.炎症性肠病的客观治疗目标及其与患者报告结局的相关性:一项真实世界研究
J Clin Med. 2025 Jul 4;14(13):4733. doi: 10.3390/jcm14134733.
3
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease.

本文引用的文献

1
Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.中国炎症性肠病患者的癌症风险和化学预防:一项基于人群的队列研究。
Scand J Gastroenterol. 2020 Mar;55(3):279-286. doi: 10.1080/00365521.2020.1731760. Epub 2020 Mar 2.
2
Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.抗 TNF 治疗的引入并未使炎症性肠病的住院率和肠切除术率如预期般下降:一项基于人群的中断时间序列研究。
Gut. 2020 Feb;69(2):274-282. doi: 10.1136/gutjnl-2019-318440. Epub 2019 Jun 12.
3
早期积极治疗对炎症性肠病长期生化标志物模式的影响。
J Gastroenterol. 2025 May 2. doi: 10.1007/s00535-025-02244-w.
4
A Longitudinal Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: A Cohort Study in Denmark and Sweden, 2013-2021.戈利木单抗治疗溃疡性结肠炎的长期授权后安全性研究:2013 - 2021年丹麦和瑞典的队列研究
Drug Saf. 2025 May;48(5):541-558. doi: 10.1007/s40264-025-01519-8. Epub 2025 Feb 6.
5
Anxiety and Depression Are Associated with Poor Long-term Quality of Life in Moderate-to-Severe Ulcerative Colitis: Results of a 3-Year Longitudinal Study of the MOSAIK Cohort.焦虑和抑郁与中重度溃疡性结肠炎患者长期生活质量差相关:MOSAIK队列的3年纵向研究结果
Gut Liver. 2025 Mar 15;19(2):253-264. doi: 10.5009/gnl240146. Epub 2024 Nov 7.
6
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study.在 filgotinib 治疗期间溃疡性结肠炎症状反应的不同轨迹:SELECTION 研究的事后分析。
United European Gastroenterol J. 2024 Nov;12(9):1243-1255. doi: 10.1002/ueg2.12686. Epub 2024 Oct 25.
7
Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.优特克单抗、英夫利昔单抗及联合疗法治疗中度至重度活动性溃疡性结肠炎的比较——一项随机、多中心、头对头COMBO-UC试验的研究方案
Front Med (Lausanne). 2024 Sep 19;11:1458998. doi: 10.3389/fmed.2024.1458998. eCollection 2024.
8
Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease.小儿炎症性肠病患者 rs3197999 多态性。
Medicina (Kaunas). 2024 Jul 31;60(8):1243. doi: 10.3390/medicina60081243.
9
Risk factors for clinical relapse in patients with ulcerative colitis who are in clinical remission but with endoscopic activity.临床缓解但存在内镜下活动的溃疡性结肠炎患者临床复发的危险因素。
JGH Open. 2024 Jul 24;8(7):e70011. doi: 10.1002/jgh3.70011. eCollection 2024 Jul.
10
Immunotherapy withdrawal by step-down to mesalamine in pediatric patients with ulcerative colitis.溃疡性结肠炎儿科患者通过逐步减量至美沙拉嗪进行免疫治疗撤药
JPGN Rep. 2024 Feb 5;5(2):97-100. doi: 10.1002/jpr3.12048. eCollection 2024 May.
The Role of the Status of Selected Micronutrients in Shaping the Immune Function.
特定微量营养素状态在塑造免疫功能中的作用。
Endocr Metab Immune Disord Drug Targets. 2019;19(8):1100-1115. doi: 10.2174/1871530319666190529101816.
4
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.系统评价与荟萃分析:5-氨基水杨酸类药物在炎症性肠病患者中的应用与结直肠肿瘤风险。
Aliment Pharmacol Ther. 2017 May;45(9):1179-1192. doi: 10.1111/apt.14023. Epub 2017 Mar 6.
5
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.
6
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.5-氨基水杨酸对炎症性肠病相关结直肠癌和发育异常的化学预防作用:一项荟萃分析的系统评价
Oncotarget. 2017 Jan 3;8(1):1031-1045. doi: 10.18632/oncotarget.13715.
7
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.早期治疗干预患者克罗恩病结局风险矩阵的开发与验证
J Crohns Colitis. 2017 Apr 1;11(4):445-453. doi: 10.1093/ecco-jcc/jjw171.
8
Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC.溃疡性结肠炎患者报告的结局与内镜及组织学表现之间的差异。
Gut. 2017 Dec;66(12):2063-2068. doi: 10.1136/gutjnl-2016-312307. Epub 2016 Sep 2.
9
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.磁共振胆管成像检测长期炎症性肠病患者硬化性胆管炎的患病率。
Gastroenterology. 2016 Oct;151(4):660-669.e4. doi: 10.1053/j.gastro.2016.06.021. Epub 2016 Jun 21.
10
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.生物疗法与炎症性肠病患者感染和恶性肿瘤风险:系统评价和网络荟萃分析。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1385-1397.e10. doi: 10.1016/j.cgh.2016.04.039. Epub 2016 May 14.